Experimental Hematology & Oncology

Experimental Hematology & Oncology accepted for inclusion in SCIE

New Content Item We are delighted to announce that Experimental Hematology & Oncology has been accepted for inclusion in Science Citation Index Expanded (SCIE), a key database of Web of Science, published by Clarivate Analytics. Starting 2020, Experimental Hematology & Oncology will be published in the annual Journal Citation Reports, at which point it will receive the associated journal metrics, such as Immediacy Index, Eigenfactor Score, and Journal Impact Factor.

Aims and scope

Experimental Hematology & Oncology is an open access journal that encompasses all aspects of hematology and oncology with an emphasis on preclinical, basic, patient-oriented and translational research. The journal acts as an international platform for sharing laboratory findings in these areas and makes a deliberate effort to publish clinical trials with 'negative' results and basic science studies with provocative findings.

Content type: Letter to the Editor
| 11 September 2019

Cabozantinib and apixaban: an hitherto unreported interaction

Authors: Daniele Santini, Fabrizio Citarella, Bruno Vincenzi, Marco Russano, Giuseppe Tonini and Marco Stellato
Content type: Review
| 11 September 2019

Role of some members of chemokine/cytokine network in the pathogenesis of thalassemia and sickle cell hemoglobinopathies: a mini review

Authors: Zahra Mousavi, Zinat Yazdani, Alireza Moradabadi, Fatemeh Hoseinpourkasgari and Gholamhossein Hassanshahi
Content type: Case report
| 10 September 2019

Autoimmune rhabdomyolysis and a multiorgan display of PD-1 inhibitor induced immune related adverse events during treatment of metastatic melanoma

Authors: Hoda Z. Pourhassan, David Tryon, Brett Schaeffer, Hamid Mirshahidi and John Wong
Content type: Review
| 22 August 2019

Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer

Authors: Zhenbin Qiu, Zihao Chen, Chao Zhang and Wenzhao Zhong
Content type: Short report
| 22 August 2019

A novel RNA variant of human concentrative nucleoside transporter 1 (hCNT1) that is a potential cancer biomarker

Authors: Chunmei Wang and John K. Buolamwini

Most recent articles RSS

View all articles

Editors-in-Chief

Kongming Wu, Tongji Medical College
Delong Liu, New York Medical College
Zihai Li, Medical University of South Carolina

Editor's quote (Dr. Delong Liu)

"Like our companion journal, Journal of Hematology & Oncology, Experimental Hematology & Oncology publishes on all aspects of hematology and oncology, which are closely intertwined and rapidly evolving fields. It also emphasizes basic and translational research, as well as patient-oriented research and clinical trials with ‘negative’ or preliminary results. The journal is an international platform for sharing findings in these areas and adheres to fast turnaround times."

Latest Tweets

Experimental Hematology & Oncology